NCT07345793

Brief Summary

Brief Summary: This project consists of two sequential experimental phases designed to analyze the immediate and 24-hour effects of three invasive physiotherapy techniques -dry needling (DN), percutaneous neuromodulation (PENS), and percutaneous electrolysis (EPE)- on muscle tone and pain perception. In the first phase, the study will be conducted on healthy volunteers to assess the physiological responses and safety profile of the interventions under controlled conditions. Each participant will receive one of the three randomly assigned interventions (DN, PENS, or EPE), applied to the upper trapezius muscle. Pain perception (Visual Analog Scale, VAS) and muscle mechanical properties (tone, stiffness, and elasticity) will be measured before and after the intervention, and after 24 hours, using the MyotonPRO device. In the second phase, the same protocol and parameters will be applied to patients with chronic neck pain, in order to compare the magnitude and persistence of the effects between healthy subjects and symptomatic individuals. This study aims to improve understanding of the short-term physiological mechanisms of invasive physiotherapy techniques and their relative effectiveness in managing chronic neck pain. The findings will contribute to the development of more precise and evidence-based treatment protocols for musculoskeletal pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 16, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

January 19, 2026

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 28, 2026

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 2, 2026

Completed
Last Updated

February 18, 2026

Status Verified

January 1, 2026

Enrollment Period

9 days

First QC Date

January 7, 2026

Last Update Submit

February 13, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    Pain perception will be measured using a 10 cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates worst imaginable pain. Participants will mark their perceived pain intensity at rest. The scale is a reliable and validated tool for assessing subjective pain in musculoskeletal disorders.

    Baseline (pre-intervention), immediately post-intervention, and 24 hours post-intervention.

Secondary Outcomes (3)

  • Muscle tone

    Baseline and immediately post-intervention, and 24 hours post-intervention

  • Muslce stiffness

    Baseline, immediately post intervention and 24 hours post-intervention

  • Muscle elasticity

    Baseline, immedialely post intervention and 24 hours post intervention

Study Arms (3)

Dry needling

EXPERIMENTAL
Procedure: Dry needling

Percutaneous electrical nerve stimulation

EXPERIMENTAL
Procedure: Percutaneous nerve stimulation

Percutaneous electrolysis

EXPERIMENTAL
Procedure: Percutaneous electrolysis

Interventions

Dry needlingPROCEDURE

Dry needling will be performed on the upper trapezius muscle at an active myofascial trigger point. A sterile, single-use solid filament needle (0.30 × 40 mm) will be inserted until eliciting three local twitch responses (LTRs). The needle will then be withdrawn immediately after obtaining the final response. The technique aims to normalize motor endplate activity and reduce local and referred pain through mechanical and neurophysiological modulation.

Dry needling

Percutaneous neuromodulation will be applied using a sterile acupuncture needle (0.30 × 40 mm) inserted near the accessory nerve pathway in the upper trapezius region. A low-frequency alternating current (10 Hz, 250 μs pulse width) will be delivered for 15 minutes using an electrotherapy device approved for clinical use. The objective is to modulate neuromuscular excitability and decrease pain perception through peripheral and central mechanisms.

Percutaneous electrical nerve stimulation

Percutaneous electrolysis will be performed by inserting a sterile acupuncture needle (0.30 × 40 mm) into the active myofascial trigger point of the upper trapezius. A galvanic current of 1 mA will be applied for three impacts of 5 seconds each using an approved electrolysis device. This technique produces a controlled local inflammatory response, promoting tissue regeneration and analgesia through electrochemical and neurophysiological effects.

Percutaneous electrolysis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 65 years.
  • Healthy individuals without any current musculoskeletal or neurological pathology.
  • Presence of a palpable myofascial trigger point in the upper trapezius muscle.
  • No neck or shoulder pain requiring medical treatment in the past three months.
  • Willingness to refrain from other physiotherapy or manual therapy interventions during the study period.
  • Ability to understand and provide written informed consent
  • Phase 2 - Patients with Chronic Neck Pain
  • Age between 18 and 65 years.
  • Diagnosis of chronic mechanical or tension-type neck pain lasting for at least 3 months.
  • Presence of at least one active myofascial trigger point in the upper trapezius muscle.
  • Pain intensity between 3 and 7 on a 10-cm Visual Analog Scale (VAS) at baseline.
  • No previous invasive physiotherapy treatments (dry needling, electrolysis, or neuromodulation) within the last 4 weeks.
  • Ability and willingness to attend all study sessions and follow-up assessments.
  • Signed informed consent before participation.

You may not qualify if:

  • History of cervical or shoulder surgery.
  • Neurological, systemic, or rheumatologic disorders affecting the cervical or upper limb region.
  • Anticoagulant therapy or known bleeding disorders.
  • Pregnancy or suspected pregnancy.
  • Skin infection, wound, or dermatological condition at or near the intervention site.
  • Use of analgesic, anti-inflammatory, or muscle relaxant medications within 48 hours prior to the intervention.
  • Prior invasive physiotherapy (dry needling, PENS, or EPE) in the target area during the past month.
  • Contraindications to electrical stimulation (for PENS or EPE groups), such as implanted pacemaker or metal implants near the treatment area.
  • Fear of needles (trypanophobia) or intolerance to invasive procedures.
  • Participation in another clinical trial within the past 3 months.
  • Refusal or inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Antonio Rejas Fisioterapia

Cuenca, Spain

Location

Related Publications (6)

  • Fernández-de-Las-Peñas C., Dommerholt J. Myofascial Trigger Points: Pathophysiology and Evidence-Informed Diagnosis and Management. Pain Medicine. 2018.

    RESULT
  • Abat F. et al. Effectiveness of percutaneous electrolysis for tendinopathies. Br J Sports Med. 2015.

    RESULT
  • Rodríguez-Sanz J. et al. Dry Needling in the Management of Musculoskeletal Pain. Brazilian Journal of Physical Therapy. 2014.

    RESULT
  • Pirri C, Manocchio N, Sorbino A, Pirri N, Foti C. Percutaneous Electrolysis for Musculoskeletal Disorders Management in Rehabilitation Settings: A Systematic Review. Healthcare (Basel). 2025 Jul 23;13(15):1793. doi: 10.3390/healthcare13151793.

  • Hoy D, March L, Woolf A, Blyth F, Brooks P, Smith E, Vos T, Barendregt J, Blore J, Murray C, Burstein R, Buchbinder R. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1309-15. doi: 10.1136/annrheumdis-2013-204431. Epub 2014 Jan 30.

  • Fejer R, Kyvik KO, Hartvigsen J. The prevalence of neck pain in the world population: a systematic critical review of the literature. Eur Spine J. 2006 Jun;15(6):834-48. doi: 10.1007/s00586-004-0864-4. Epub 2005 Jul 6.

MeSH Terms

Interventions

Dry NeedlingTranscutaneous Electric Nerve Stimulation

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesElectric Stimulation TherapyRehabilitationAnalgesiaAnesthesia and Analgesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This study is designed as a two-phase randomized experimental trial with parallel group assignment. In the first phase, healthy volunteers will be randomly assigned to one of three intervention groups: 1. Dry Needling (DN) - mechanical stimulation of an active myofascial trigger point in the upper trapezius. 2. Percutaneous Neuromodulation (PENS) - low-frequency electrical stimulation applied near the accessory nerve through an acupuncture needle. 3. Percutaneous Electrolysis (EPE) - galvanic current (1 mA, three impacts of 5 seconds) applied through a needle at the trigger point. All participants will undergo a single treatment session. Assessments of pain intensity (VAS) and muscle mechanical properties (tone, stiffness, elasticity measured by MyotonPRO) will be performed before the intervention, immediately after, and 24 hours later. In the second phase, the same study design, intervention parameters, and outcome measures will be applied to a population of patients with chroni
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist

Study Record Dates

First Submitted

January 7, 2026

First Posted

January 16, 2026

Study Start

January 19, 2026

Primary Completion

January 28, 2026

Study Completion

February 2, 2026

Last Updated

February 18, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations